Effects of oleoylethanolamide supplementation on atherogenic indices and hematological parameters in patients with nonalcoholic fatty liver disease: A clinical trial

Background: Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of chronic liver disease in the world. The current interventional trial aimed to evaluate the effects of supplementation with oleoylethanolamide (OEA) in combination with weight loss intervention on some atherogenic ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Tutunchi, Helda, Naeini, Fatemeh, Saghafi-Asl, Maryam, Farrin, Nazila, Monshikarimi, Alireza, Ostadrahimi, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722997/
https://www.ncbi.nlm.nih.gov/pubmed/33312933
http://dx.doi.org/10.34172/hpp.2020.56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722997/
https://www.ncbi.nlm.nih.gov/pubmed/33312933
http://dx.doi.org/10.34172/hpp.2020.56

Ejemplares similares